Natraceutical, from Spain

Listed in:

Business: Pharmaceutical, Foods, Healthcare,

Auditor: PWC.

Last Balances States (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Total Assets 85.066 88.059 -3.4
Total Liabilities
8.231
10.914 -24.58
Equity
76.835
77.145 -0.4
Working Capital
8.040
14.602 -44.94
July 14, 2015

Basic Stock Information

Last Quote (EUR)
0.262
PER
90.35
Capitalization (Mns of EUR)
84.995
Capitalization/Equity
1.1062
Last month variation (%)
2.344
Last 3 months variation (%)
-14.379
Last 6 months variation (%)
31.000
Last 12 months variation (%)
9.167

Last Financial Statement (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Revenue
17.736
18.159 -2.33
EBIT
1.707
2.269 -24.77
Net Profit
1.218
2.381 -48.85
ROCE (%) 2.194 2.922 -24.91
ROE 0.016 0.031 -48.39
ROA 0.014 0.027 -48.15
Net Profit over revenue 0.069 0.131 -47.33
EBIT over revenue 0.096 0.125 -23.2
EBITDA over revenue 0.109 0.138 -21.01
Assets Rotation 0.208 0.206 0.97
Earning per share (EUR) 0.00371 0.00724 -48.76

Stock-Market Evolution

Key Figures (EUR)

Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
H1 17.736 1.942 1.707 1.833 1.218 0.069 0.096 0.016 0.014 8.040 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 31.370 2.569 2.014 2.093 0.953 0.030 0.064 0.013 0.011 6.208 Details
H2 13.211 0.058 -0.255 -0.273 -1.428 -0.108 -0.019 -0.019 -0.017 6.208 Details
H1 18.159 2.511 2.269 2.366 2.381 0.131 0.125 0.031 0.027 14.602 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 29.926 0.856 0.128 -1.000 -0.006 0.000 0.004 0.000 0.000 24.120 Details
H2 13.067 -0.222 -0.596 7.760 8.812 0.674 -0.046 0.102 0.090 24.120 Details
H1 16.859 1.078 0.724 -8.760 -8.818 -0.523 0.043 -0.114 -0.059 23.318 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 29.485 -4.136 -16.676 16.609 16.066 0.545 -0.566 0.186 0.097 42.020 Details
H2 10.570 -3.215 -15.136 15.698 15.155 1.434 -1.432 0.175 0.092 42.020 Details
H1 18.915 -0.921 -1.540 0.911 0.911 0.048 -0.081 0.012 0.005 3.520 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 38.841 -6.327 -19.166 -19.508 -22.618 -0.582 -0.493 -0.308 -0.124 -75.286 Details
H2 14.273 -7.246 -19.576 -19.243 -22.353 -1.566 -1.372 -0.305 -0.122 -75.286 Details
H1 24.568 0.919 0.410 0.783 0.783 0.032 0.017 0.008 0.004 7.469 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 134.616 -3.291 -14.742 -43.912 -44.907 -0.334 -0.110 -0.480 -0.224 -68.283 Details
H2 58.503 -8.192 -16.403 -41.966 -42.763 -0.731 -0.280 -0.457 -0.214 -68.283 Details
H1 76.113 4.904 1.664 -1.943 -2.076 -0.027 0.022 -0.015 -0.007 15.474 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 161.019 22.177 12.021 4.764 1.491 0.009 0.075 0.011 0.005 17.780 Details
H2 66.708 7.633 3.210 -1.182 -4.339 -0.065 0.048 -0.033 -0.014 17.780 Details
H1 94.311 14.112 9.746 5.946 5.830 0.062 0.103 0.040 0.019 26.095 Details

Additional information

  • Capitalization: Total number of shares x (1 - Treasury shares) x Last Quote = (328713946) x (1 - 0.0131 ) x (0.262 EUR) = 84.995 Mns of EUR
  • PER: Last Quote (0.262 EUR) / Last annual earning per share (0.00290) = 90.345

News